Variations in Risk Factors across Different Periods of Stroke and Transient Ischemic Attack Recurrence.

IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY
European Neurology Pub Date : 2024-01-01 Epub Date: 2024-07-27 DOI:10.1159/000540571
Sang-Hun Lee, Jin-Man Jung, Jae-Chan Ryu, Moon-Ho Park
{"title":"Variations in Risk Factors across Different Periods of Stroke and Transient Ischemic Attack Recurrence.","authors":"Sang-Hun Lee, Jin-Man Jung, Jae-Chan Ryu, Moon-Ho Park","doi":"10.1159/000540571","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Accurately discerning periods of heightened risk of stroke or transient ischemic attack (TIA) recurrence and managing modifiable risk factors are essential for minimizing overall recurrence risk. This study identified differences in the timing of stroke or TIA recurrence based on risk factors and patient characteristics to develop strategies for reducing recurrence in clinical practice.</p><p><strong>Methods: </strong>We retrospectively selected patients with ischemic stroke or TIA at the Korea University Ansan Hospital Stroke Center between March 2014 and December 2021 using the prospective institutional database of the Korea University Stroke Registry. We collected demographic, clinical data, and categorized participants by recurrence timing (early within or late after 3 months). Using multinomial logistic regression analysis, we examined variables associated with early and late recurrent stroke or TIAs.</p><p><strong>Results: </strong>Among 3,646 patients, 255 experienced a recurrent stroke or TIA and 3,391 experienced their first stroke or TIA. Multinomial logistic regression analysis revealed significant associations between early recurrent stroke or TIA and diabetes mellitus (odds ratio [OR]: 1.98, 95% confidence interval [CI]: 1.25-3.15), other determined etiologies in the Trial of Org 10172 in the Acute Stroke Treatment classification (OR: 3.00, 95% CI: 1.37-6.61), and white matter changes (OR: 1.97, 95% CI: 1.17-3.33). Late recurrence showed a significant correlation with TIA (OR: 2.95, 95% CI: 1.52-5.71) and cerebral microbleeds (OR: 2.22, 95% CI: 1.32-3.75).</p><p><strong>Conclusion: </strong>Substantial differences in factors contribute to stroke or TIA recurrence based on timing. Managing the risk of recurrence in clinical practice necessitates accurate identification of heightened risk periods and rigorous control of modifiable risk factors.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"213-222"},"PeriodicalIF":2.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651328/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000540571","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Accurately discerning periods of heightened risk of stroke or transient ischemic attack (TIA) recurrence and managing modifiable risk factors are essential for minimizing overall recurrence risk. This study identified differences in the timing of stroke or TIA recurrence based on risk factors and patient characteristics to develop strategies for reducing recurrence in clinical practice.

Methods: We retrospectively selected patients with ischemic stroke or TIA at the Korea University Ansan Hospital Stroke Center between March 2014 and December 2021 using the prospective institutional database of the Korea University Stroke Registry. We collected demographic, clinical data, and categorized participants by recurrence timing (early within or late after 3 months). Using multinomial logistic regression analysis, we examined variables associated with early and late recurrent stroke or TIAs.

Results: Among 3,646 patients, 255 experienced a recurrent stroke or TIA and 3,391 experienced their first stroke or TIA. Multinomial logistic regression analysis revealed significant associations between early recurrent stroke or TIA and diabetes mellitus (odds ratio [OR]: 1.98, 95% confidence interval [CI]: 1.25-3.15), other determined etiologies in the Trial of Org 10172 in the Acute Stroke Treatment classification (OR: 3.00, 95% CI: 1.37-6.61), and white matter changes (OR: 1.97, 95% CI: 1.17-3.33). Late recurrence showed a significant correlation with TIA (OR: 2.95, 95% CI: 1.52-5.71) and cerebral microbleeds (OR: 2.22, 95% CI: 1.32-3.75).

Conclusion: Substantial differences in factors contribute to stroke or TIA recurrence based on timing. Managing the risk of recurrence in clinical practice necessitates accurate identification of heightened risk periods and rigorous control of modifiable risk factors.

中风和短暂性脑缺血发作复发不同时期风险因素的变化。
导言:准确识别卒中或短暂性脑缺血发作(TIA)复发风险的高发期并管理可改变的风险因素对于最大限度地降低总体复发风险至关重要。本研究根据风险因素和患者特征确定了卒中或 TIA 复发时间的差异,以便在临床实践中制定减少复发的策略:方法:我们利用韩国大学卒中登记处的前瞻性机构数据库,回顾性地选择了 2014 年 3 月至 2021 年 12 月期间在韩国大学安山医院卒中中心就诊的缺血性卒中或 TIA 患者。我们收集了人口统计学和临床数据,并按复发时间(3 个月内早期或 3 个月后晚期)对参与者进行了分类。通过多项式逻辑回归分析,我们研究了与早期和晚期复发中风或 TIA 相关的变量:结果:在 3,646 名患者中,255 人复发了中风或 TIA,3,391 人首次出现中风或 TIA。多项式逻辑回归分析显示,早期复发性卒中或 TIA 与糖尿病(几率比 [OR] 1.98,95% 置信区间 [CI]1.25-3.15)、急性卒中治疗分类中 Org 10172 试验确定的其他病因(OR 3.00,95% CI 1.37-6.61)和白质改变(OR 1.97,95% CI 1.17-3.33)有显著相关性。晚期复发与TIA(OR 2.95,95% CI 1.52-5.71)和脑微出血(OR 2.22,95% CI 1.32-3.75)有显著相关性:结论:导致卒中或 TIA 复发的因素在时间上存在很大差异。在临床实践中管理复发风险需要准确识别高危时期并严格控制可改变的风险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Neurology
European Neurology 医学-临床神经学
CiteScore
4.40
自引率
4.20%
发文量
51
审稿时长
4-8 weeks
期刊介绍: ''European Neurology'' publishes original papers, reviews and letters to the editor. Papers presented in this journal cover clinical aspects of diseases of the nervous system and muscles, as well as their neuropathological, biochemical, and electrophysiological basis. New diagnostic probes, pharmacological and surgical treatments are evaluated from clinical evidence and basic investigative studies. The journal also features original works and reviews on the history of neurology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信